Printer Friendly

Fujimori Named to Boston Scientific Board of Directors.

M2 PHARMA-July 15, 2016-Fujimori Named to Boston Scientific Board of Directors

(C)2016 M2 COMMUNICATIONS

- Yoshiaki Fujimori has been elected to US-based medical device company Boston Scientific Corp.'s (NYSE: BSX) board of directors, effective immediately, the company said.

Fujimori is an adviser to the LIXIL Group Corp. for which he served as president and chief executive officer from 2011 to 2016.

Prior to joining LIXIL, Fujimori spent 25 years with GE, including positions as senior vice president and chief executive officer of a number of Asian and global business divisions, including medical systems, plastics and capital, and was a member of the corporate executive council.

Next, he served as chairman, president and CEO of GE Japan for more than three years.

Fujimori started his career at Japanese trading company Nissho Iwai Corp. (now Sojitz).

He serves as an external director of Tokyo Electric Power Co, a role he has held since June 2012. Fujimori is also an external director for Takeda Pharmaceutical Co Ltd.

Fujimori previously served as chairman of the Japan Construction Material and Housing Equipment Industries Federation.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jul 15, 2016
Words:191
Previous Article:US FDA Approves Novocure's Second Generation Optune TTFields System.
Next Article:Cardiome Pharma Corp secures pricing approval and reimbursement in Italy for ESMOCARD and ESMOCARD LYO.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters